.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

HALOTHANE Drug Profile

« Back to Dashboard
Halothane is a drug marketed by Halocarbon, Hospira, and BH. and is included in three NDAs.

The generic ingredient in HALOTHANE is halothane. There are four drug master file entries for this compound. Additional details are available on the halothane profile page.

Summary for Tradename: HALOTHANE

Patents:0
Applicants:3
NDAs:3

Clinical Trials for: HALOTHANE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halocarbon
HALOTHANE
halothane
LIQUID;INHALATION080810-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Hospira
HALOTHANE
halothane
LIQUID;INHALATION083254-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Bh
HALOTHANE
halothane
LIQUID;INHALATION084977-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc